Mechanistically, miR-584-5p promoted senescence in GC cells by downregulating WWP1 and activating TGF-β signaling, and implied that miR-584-5p may have therapeutic potential for human GC (Li Q. et al., 2017). This evidence concerns the gene TGFB1 and gastric cancer.